Literature DB >> 26722664

Orthotopic liver transplantation for giant liver haemangioma: A case report.

Undine G Lange1, Julian N Bucher1, Markus B Schoenberg1, Christian Benzing1, Moritz Schmelzle1, Tanja Gradistanac1, Steffen Strocka1, Hans-Michael Hau1, Michael Bartels1.   

Abstract

In liver haemangiomas, the risk of complication rises with increasing size, and treatment can be obligatory. Here we present a case of a 46-year-old female who suffered from a giant haemangioma causing severe portal hypertension and vena cava compression, leading to therapy refractory ascites, hyponatremia and venostasis-associated thrombosis with pulmonary embolism. The patients did not experience tumour rupture or consumptive coagulopathy. Surgical resection was impossible because of steatosis of the non-affected liver. Orthotopic liver transplantation was identified as the only treatment option. The patient's renal function remained stable even though progressive morbidity and organ allocation were improbable according to the patient's lab model for end-stage liver disease (labMELD) score. Therefore, non-standard exception status was approved by the European organ allocation network "Eurotransplant". The patient underwent successful orthotopic liver transplantation 16 mo after admission to our centre. Our case report indicates the underrepresentation of morbidity associated with refractory ascites in the labMELD-based transplant allocation system, and it indicates the necessity of promptly applying for non-standard exception status to enable transplantation in patients with a severe clinical condition but low labMELD score. Our case highlights the fact that liver transplantation should be considered early in patients with non-resectable, symptomatic benign liver tumours.

Entities:  

Keywords:  Giant haemangioma; Lab model for end-stage liver disease -based allocation system; Non-standard exception status; Orthotopic liver transplantation; Therapy refractory ascites

Year:  2015        PMID: 26722664      PMCID: PMC4689947          DOI: 10.5500/wjt.v5.i4.354

Source DB:  PubMed          Journal:  World J Transplant        ISSN: 2220-3230


  37 in total

1.  Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Authors:  Douglas M Heuman; Souheil G Abou-Assi; Adil Habib; Leslie M Williams; R Todd Stravitz; Arun J Sanyal; Robert A Fisher; Anastasios A Mihas
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

2.  Regional variations in peer reviewed liver allocation under the MELD system.

Authors:  Hector Rodriguez-Luna; Hugo E Vargas; Adyr Moss; Kunam S Reddy; Richard B Freeman; David Mulligan
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

3.  Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.

Authors:  Ma Somsouk; Rachel Kornfield; Eric Vittinghoff; John M Inadomi; Scott W Biggins
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

4.  Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic disease.

Authors:  Jan Lerut; Olga Ciccarelli; Matthieu Rutgers; Giuseppe Orlando; Jules Mathijs; Etienne Danse; Eric Goffin; Jean-François Gigot; Pierre Goffette
Journal:  Transpl Int       Date:  2005-05       Impact factor: 3.782

5.  Orthotopic liver transplantation in a patient with a giant cavernous hemangioma of the liver and Kasabach-Merritt syndrome.

Authors:  I J Klompmaker; M J Sloof; J van der Meer; G M de Jong; K M de Bruijn; J L Bams
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

6.  Natural history of hepatic haemangiomas: clinical and ultrasound study.

Authors:  L Gandolfi; P Leo; L Solmi; E Vitelli; G Verros; A Colecchia
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

7.  Management of giant hemangioma of the liver: resection versus observation.

Authors:  Thomas Schnelldorfer; Adam L Ware; Rory Smoot; Cathy D Schleck; William S Harmsen; David M Nagorney
Journal:  J Am Coll Surg       Date:  2010-10-25       Impact factor: 6.113

Review 8.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

9.  Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review.

Authors:  Parsia A Vagefi; Ingo Klein; Bruce Gelb; Bilal Hameed; Stephen L Moff; Jeff P Simko; Oren K Fix; Helge Eilers; John R Feiner; Nancy L Ascher; Chris E Freise; Nathan M Bass
Journal:  J Gastrointest Surg       Date:  2010-06-12       Impact factor: 3.452

10.  Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report.

Authors:  J H Longeville; P de la Hall; P Dolan; A W Holt; P E Lillie; J A Williams; R T Padbury
Journal:  HPB Surg       Date:  1997
View more
  5 in total

Review 1.  Liver Transplantation for Giant Hemangioma Complicated by Kasabach-Merritt Syndrome: A Case Report and Literature Review.

Authors:  Yi Zhao; Carley E Legan
Journal:  Am J Case Rep       Date:  2022-05-23

2.  Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report.

Authors:  Ju Hyun Lee; Chang Jin Yoon; Young Hoon Kim; Ho-Seong Han; Jai Young Cho; Haeryoung Kim; Eun Sun Jang; Jin-Wook Kim; Sook-Hyang Jeong
Journal:  Clin Mol Hepatol       Date:  2017-07-19

3.  Orthotopic liver transplantation for Management of a Giant Liver Hemangioma: a case report and review of literature.

Authors:  Hesameddin Eghlimi; Peyman Arasteh; Nazanin Azade
Journal:  BMC Surg       Date:  2020-06-29       Impact factor: 2.102

4.  Liver transplantation for giant hemangioma of the liver: A case report and review of the literature.

Authors:  Yun Zhao; Xiu-Ping Li; Yuan-Yuan Hu; Ji-Chang Jiang; Li-Jin Zhao
Journal:  Front Med (Lausanne)       Date:  2022-09-15

Review 5.  Benign Liver Tumors.

Authors:  Karl J Oldhafer; Victoria Habbel; Katja Horling; Georgios Makridis; Kim Caroline Wagner
Journal:  Visc Med       Date:  2020-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.